Morgan Stanley Capital Partners agreed to sell veterinary clinic chain Pathway Vet Alliance LLC to TSG Consumer Partners in a deal worth at least $2 billion, including debt, reported the Wall Street Journal.
The private-equity arm of Morgan Stanley Investment Management bought a stake in Pathway Vet in 2016 and expanded its operations through acquisitions. Further details of the deal weren’t available and it’s unclear how much debt TSG plans to use to finance the transaction, according to Dow Jones.
Pet owners in the US are expected to spend nearly $100 billion on their pets this year on everything from pet food to toys, an increase of around $5 billion on last year, according to research produced by the American Pet Products Association. Nearly a third of this expenditure is estimated to go toward paying vet bills, the research shows.
These trends have attracted large companies to the sector, including Mars Inc., best known for its candy bars, and consumer-focused investor JAB Holding which owns Krispy Kreme doughnuts.
Last year, for example, JAB bought a stake in Compassion-First Pet Hospitals, a chain of US vet clinics, in a $1.22 billion deal. Mars bought pet health business AniCura Holding AB for close to €2 billion the year before.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Supreme Court Declines to Hear Realtors’ Appeal, DOJ Antitrust Probe Moves Forward
Jan 13, 2025 by
CPI
Commerzbank Chairman Doubts Amicable Merger with UniCredit After Stake Acquisition
Jan 13, 2025 by
CPI
Senator Warren Presses HUD Nominee on Rent Price-Fixing
Jan 13, 2025 by
CPI
Epic Games CEO Accuses Tech Giants of Shifting Loyalties to Court Trump Administration
Jan 13, 2025 by
CPI
Apple’s New Developer Fees Face Renewed Scrutiny from EU Antitrust Regulators
Jan 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand